ALDH-dependent GLUT1 upregulation contributes to the activation of glycolysis and survival of cancer stem cells; the synergistic role of inhibition of ALDH or GLUT1 combined with taxane suppresses the tumorigenesis, which provides a new prospect for EC treatment [86]. Here, SLC2A1 is linked to cancer.